$CHRS 4/A SEC Filings

Filed On	Filing
11 Feb 2022	Form 4/A: Healy James, Director Granted 27,000 Stock Option (Right to Buy)
11 Feb 2022	Form 4/A: Stolper Mark, Director Granted 27,000 Stock Option (Right to Buy)
11 Feb 2022	Form 4/A: Tzoumakas Kimberly Jo, Director Granted 27,000 Stock Option (Right to Buy)
11 Feb 2022	Form 4/A: Wahlstrom Mats, Director Granted 27,000 Stock Option (Right to Buy)
15 Jan 2019	Form 4/A: Vexler Vladimir, Chief Scientific Officer Granted 35,000 Stock Option (Right to Buy)
14 Jan 2019	Form 4/A: Vexler Vladimir, Chief Scientific Officer Granted 35,000 Stock Option (Right to Buy)
26 May 2016	Form 4/A: Wahlstrom Mats, Director Acquired 1,000,000 8.2% Senior Convertible Notes due 2022 (Open Market Purchase) ($22.4M)
26 May 2016	Form 4/A: Wahlstrom Mats, Director Sold 6,372 shares ($213K)
04 May 2016	Form 4/A: Watler Peter K., Chief Technical Officer Granted 137,500 Stock Option (Right to Buy)
27 May 2015	Form 4/A: Troendle August J., Director Granted 20,000 Stock Option (Right to Buy)
27 May 2015	Form 4/A: Lawlis V Bryan, Director Granted 51,250 Stock Option (Right to Buy)
27 May 2015	Form 4/A: Healy James, Director Acquired 96,110 shares (Other Transaction) · Acquired 239,397 shares (Other Transaction) · Granted 45,000 Stock Option (Right to Buy)
27 May 2015	Form 4/A: Richards Christos, Director Granted 20,000 Stock Option (Right to Buy)
27 May 2015	Form 4/A: Wahlstrom Mats, Director Granted 95,000 Stock Option (Right to Buy)
27 May 2015	Form 4/A: Satvat Ali J., Director Granted 20,000 Stock Option (Right to Buy)
27 May 2015	Form 4/A: Szela Mary T, Director Granted 20,000 Stock Option (Right to Buy)

Comments